282 Prognostic value of exercise time in children with chronic heart failure: one year follow-up

2007 ◽  
Vol 6 (1) ◽  
pp. 59-59
Author(s):  
G GUIMARAES ◽  
A MOCELIN ◽  
P CAMARGO ◽  
E BOCCHI
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Prognostic Value ◽  
Exercise Time ◽  
One Year

710 Renal dysfunction in patients with diastolic heart failure, different biochemical parameters and its prognostic value in one year follow up

2006 ◽  
Vol 5 (1) ◽  
pp. 163-163
Author(s):  
M ROIK ◽  
M STARCZEWSKA ◽  
S STAWICKI ◽  
A OREZIAK ◽  
J KOCHANOWSKI ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Dysfunction ◽  
Biochemical Parameters ◽  
Prognostic Value ◽  
Diastolic Heart Failure ◽  
One Year

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial

2006 ◽  
Vol 152 (4) ◽  
pp. 713.e1-713.e7 ◽  
Author(s):  
Romuald Wojnicz ◽  
Jolanta Nowak ◽  
Bożena Szyguła-Jurkiewicz ◽  
Krzysztof Wilczek ◽  
Andrzej Lekston ◽  
...  
Keyword(s):  
Heart Failure ◽  
Molecular Weight ◽  
Chronic Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Randomized Trial ◽  
Adjunctive Therapy ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
One Year

scholarly journals Benefit of Ambulatory Management of Patients with Chronic Heart Failure by Protocolized Follow-Up Therapeutic Education and Remote Monitoring Solution: An Original Study in 159 Patients

2020 ◽  
Vol 9 (10) ◽  
pp. 3106
Author(s):  
Anne Jenneve ◽  
Noel Lorenzo-Villalba ◽  
Guy Courdier ◽  
Samy Talha ◽  
François Séverac ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Education Program ◽  
Remote Monitoring ◽  
Therapeutic Education ◽  
Left Ventricular Ejection ◽  
The Mean ◽  
One Year ◽  
Heart Condition

This study sought to determine whether the implementation of regular and structured follow-up of patients with chronic heart failure (CHF), combined with therapeutic education and remote monitoring solution, leads to better management. This was a single-center retrospective study conducted in a cohort of patients with proven CHF who were followed up in the Mulhouse region (France) between January 2016 and December 2017 by the Unité de Suivi des Patients Insuffisants Cardiaques (USICAR) unit. These patients received regular protocolized follow-up, a therapeutic education program, and several used a telemedicine platform for a two-year period. The primary endpoint was the number of days hospitalized for heart failure (HF) per patient per year. The main secondary endpoints included the number of days hospitalized for a heart condition other than HF and the number of hospital stays for HF per patient. These endpoints were collected during the year preceding enrollment, at one year of follow-up, and at two years of follow-up. The remote monitoring solution was evaluated on the same criterion. Overall, 159 patients with a mean age of 72.9 years were included in this study. They all had CHF, mainly NYHA Class I-II (88.7%), predominantly of ischemic origin (50.9%), and with altered left ventricular ejection fraction in 69.2% of cases. The mean number of days hospitalized for HF per patient per year was 8.33 (6.84–10.13) in the year preceding enrollment, 2.6 (1.51–4.47) at one year of follow-up, and 2.82 at two years of follow-up (1.30–6.11) (p < 0.01 for both comparisons). The mean number of days hospitalized for a heart condition other than HF was 1.73 (1.16–2.6), 1.81 (1.04–3.16), and 1.32 (0.57–3.08), respectively (p = ns). The percentage of hospitalization for HF for each patient was 69.5% (60.2–77.4), 16.2% (10–25.2), and 19.3% (11–31.8), respectively (p < 0.001 for both comparisons). In the group telemedicine, the mean number of days hospitalized for HF per patient per year was 8.33 during the year preceding enrollment, 2.3 during the first year of follow-up, and 1.7 during the second. This difference was significant (p < 0.001). The “number of days hospitalized for a heart condition other than HF” was significantly reduced in the group of patient’s beneficiating from the remote monitoring solution. This study demonstrates the value of a protocolized follow-up associated with a therapeutic optimization, therapeutic education program, and the use of a remote monitoring solution to improve the management of ambulatory patients with CHF, particularly of moderate severity.

scholarly journals Are de novo acute heart failure and acutely worsened chronic heart failure two subgroups of the same syndrome?

2010 ◽  
Vol 138 (3-4) ◽  
pp. 162-169
Author(s):  
Marko Banovic ◽  
Zorana Vasiljevic-Pokrajcic ◽  
Bosiljka Vujisic-Tesic ◽  
Sanja Stankovic ◽  
Ivana Nedeljkovic ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Acute Heart Failure ◽  
De Novo ◽  
Left Ventricular ◽  
Clinical Severity ◽  
Left Ventricular Ejection ◽  
One Year ◽  
Common Manifestation

Introduction. Acute heart failure (AHF) is one of the most common diseases in emergency medicine, associated with poor prognosis and high in-hospital and long-term mortality. Objective. To investigate clinical presentation of patients with de novo AHF and acute worsening of chronic heart failure (CHF) and to identify differences in blood levels of biomarkers and echocardiography findings. Methods. This prospective study comprised 64 consecutive patients being grouped according to the onset of the disease into patients with the de novo AHF (45.3%), and patients with acute worsening of CHF (54.7%). Results. Acute congestion (60%) was the most common manifestation of de novo AHF, whereas pulmonary oedema (43.1%) was the most common manifestation of acutely decompensated CHF. Patients with acutely decompensated CHF had significantly higher blood values of creatinine (147.10 vs 113.16 ?mol/l; p<0.05), urea (12.63 vs 7.82 mmol/l; p<0.05), BNP (1440.11 vs 712.24 pg/ml; p<001) and NTproBNP (9097.00 vs 2827.70 pg/ml; p<0.01) on admission, and lower values of M-mode left ventricular ejection fraction (LVEF) during hospitalization (49.44% vs 42.94%; p<0.05). The follow-up after one year revealed still significantly higher BNP (365.49 vs 164.02 pg/ ml; p<0.05) and lower average values of both LVEF in patients with acutely worsened CHF (46.62% vs 54.41% and 39.52% vs 47.88%; p<0.05). Conclusion. Considering differences in clinical severity on admission, echocardiography and natriuretic peptide values during hospitalization and after one year follow-up, de novo AHF and acutely worsened CHF are two different subgroups of the same syndrome.

scholarly journals Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction

2017 ◽  
Vol 26 (6) ◽  
pp. 931-938 ◽  
Author(s):  
Karolina Wojtczak-Soska ◽  
Agata Sakowicz ◽  
Tadeusz Pietrucha ◽  
Kamil Janikowski ◽  
Malgorzata Lelonek
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Ejection Fraction ◽  
Soluble St2 ◽  
Reduced Ejection Fraction ◽  
One Year

scholarly journals Effect of Platelet Count on Prognostic Value in Patients with Chronic Heart Failure

2020 ◽  
Author(s):  
Zhi Li ◽  
Zhenyu Jiao ◽  
Yang Xie ◽  
Yanbing Li
Keyword(s):  
Heart Failure ◽  
Platelet Count ◽  
Chronic Heart Failure ◽  
Prognostic Value ◽  
Composite Endpoint ◽  
Plate Count ◽  
Cox Proportional Hazard ◽  
Cox Proportional Hazard Models ◽  
Low Platelet Count

Abstract Background: The prognostic value of platelet count in chronic heart failure (CHF) is not clearly established. The present study aimed to assesse the independent prognostic value of platelet count in patients with CHF.Methods: From Januay 2016 to December 2019, 1162 patients with a discharge diagnosis of CHF were recorded in present study. The patients were divided into two groups according to the platelet count: low platelet count (LP, ≦140,000/μl) and high plate count (HP, >140,000/μl). The main outcomes were defined as all-cause death or cardiogenic rehospitalization within 3 years. Survival analysis and Cox proportional hazard models adjusted by an established risk score were performed. Results: During 3 years follow-up, the overall main outcomes including all-cause death (P=0.0475) and composite endpoint events of all-cause death or cardiogenic rehospitalization (P=0.0053) were higher in LP group than in those with HP group. After adjusting for other covariables, including gender, age, et al., low platelet count was related to increased the risk of main outcomes during 3 years follow-up (all-cause death, HR:1.151, 95%CI: 1.082-1.670, P=0.040; composite endpoint events, HR: 1.313, 95%CI: 1.152-1.964, P=0.016). Conclusions: Low platelet count was associated with risk for higher adverse outcome in patients with CHF.

Sign in / Sign up

Export Citation Format

Share Document